Point of Care Testing for Advanced Practitioners (Paramedics) (POCTPara)

September 22, 2021 updated by: Dr Fiona Bell, Yorkshire Ambulance Service NHS Trust

Point of Care Testing (POCT) for Advanced Practitioners (Paramedics) in Urgent and Emergency Care: a Single Site Feasibility Study

Point of care testing (POCT) is described as a laboratory test conducted near the patient with a rapid result obtained through a portable analysing device, as opposed to the collection of a blood sample being transferred to a central laboratory for analysis and reporting.

Over the past 15 years increasing emphasis has been placed upon the paramedic profession as a possible solution to addressing the increasing demands placed on emergency departments. This is largely viewed through the ability of paramedics to assess patients calling 999 and manage a patient's condition away from the emergency department, with sufficient evidence supporting the role of the paramedic to develop competencies to manage larger volumes of patients.

This feasibility study will seek to understand whether paramedics report that the use of POCT devices is useful in safe clinical decision making with patients in the community, and if it is possible to use the Abbott i-STAT device in the urgent and emergency care setting for those patients where management within the community is being considered.

Given that there is very little evidence in this subject area, the research should start to inform the potential for future innovations in paramedic and community practice, and build on the body of evidence regarding POCT by paramedics related to community management.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- Paramedic Participants

Inclusion criteria:

  • HCPC registered paramedics employed as advanced practitioners
  • From the selected advanced practitioner team (Sheffield)
  • Able to provide informed consent
  • Willing to undergo training and to deliver intervention
  • Willing to undergo training to participate in study measures and processes
  • Willing to take part in the focus group

Patient Participants

Inclusion criteria:

  • Adult patients aged 18 years old and over.
  • Registered with a GP Surgery in the Sheffield CCG boundary.
  • In their normal home environment, care home, nursing home or step up intermediate bed service, experiencing an ambulatory sensitive presentation related to falls, frailty, mild to moderate breathlessness, or non-specific general illness and receiving an ambulance service response from participating advanced practitioners (paramedics).
  • Who do not require immediate life-saving intervention/immediate transfer to ED.
  • Able to give written consent during the call-out.

Exclusion Criteria:

-

Paramedic Participants:

• Any HCPC registered advanced practitioner (paramedic) who is currently under investigation for fitness to practice.

Patient Participants

  • Patients requiring emergency intervention and immediate transfer to hospital.
  • Patient does not have mental capacity.
  • Clinical presentations that should not have any delayed on scene time, meeting the criteria outlined in the YAS policy for the assessment, conveyance and referral of patients, for example detailing the NEWS2 score and other appropriate clinical screening tools that assist in the decision making regarding the decision to convey or refer for community management.
  • Non-English speaking patients.
  • End of life care patients.
  • Patients residing in prison.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Abbott i-stat Allinity
Randomised patients to this arm receive the application of the point of care testing device to provide further diagnostic information to assist clinical decision making.
Point of care testing venous blood diagnostic device.
Other Names:
  • Abbott i-stat Allinity
Placebo Comparator: Usual Care
Randomised patients to this arm receive usual care.
Usual care provided to patient without use of point of care testing device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported impact of using POCT device
Time Frame: 1.5 hours focus group at end of study
Qualitative focus group data measuring perceived self-reported impact by advanced practitioner (paramedic).
1.5 hours focus group at end of study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non-conveyance rate
Time Frame: Through study completion, expected to be 6 months
Proportion of cases not conveyed to hospital
Through study completion, expected to be 6 months
72 hour re-contact rate
Time Frame: Through study completion, expected to be 6 months
Proportion of non-conveyed hospital where there was a re-contact to the ambulance service
Through study completion, expected to be 6 months
Type of POCT cartridges used.
Time Frame: During the procedure
Type of POCT cartridges used.
During the procedure
Number of POCT cartridges used.
Time Frame: During the procedure
Number of POCT cartridges used.
During the procedure
Number of successful and unsuccessful attempts in using the POCT device.
Time Frame: During the procedure
Number of successful and unsuccessful attempts in using the POCT device recorded as a measurement of failure rates
During the procedure
Length of time on scene.
Time Frame: immediately after the patient care episode has ended
Understanding any changes to time spent with patient
immediately after the patient care episode has ended
Number of patients who receive POCT.
Time Frame: Through study completion, expected to be 6 months
Descriptive data to understand how many patients were eligible for the POCT device
Through study completion, expected to be 6 months
Patient demographics and presentations where POCT is applied - age, gender, NEWS2 score, clinical condition.
Time Frame: Through study completion, expected to be 6 months
Descriptive data to understand patient characteristics of those patients enrolled into study
Through study completion, expected to be 6 months
Feasibility of patient randomisation process
Time Frame: Through study completion, expected to be 6 months
Descriptive data to record number of successful and unsuccessful attempts at randomisation of eligible patients
Through study completion, expected to be 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Andrew Hodge, Yorkshire Ambulance Service

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2021

Primary Completion (Anticipated)

March 1, 2022

Study Completion (Anticipated)

May 1, 2022

Study Registration Dates

First Submitted

August 6, 2021

First Submitted That Met QC Criteria

September 22, 2021

First Posted (Actual)

September 23, 2021

Study Record Updates

Last Update Posted (Actual)

September 23, 2021

Last Update Submitted That Met QC Criteria

September 22, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Point of Care Testing

Clinical Trials on Interventional Diagnostic Device Arm

Subscribe